{"database": "lobbying", "table": "lobbying_activities", "rows": [[951924, "10f277a0-633e-4e8d-8a07-65792150dbf6", "Q2", "MEHLMAN CONSULTING, INC.", 284950, "AMERICAN CLINICAL LABORATORY ASSOCIATION", 2010, "second_quarter", "MED", "Health reform law implementation issues including application of medical device tax to clinical laboratory tests and cut to laboratory fee schedule update.     H.R. 4213/S. 3551, American Jobs and Closing Tax Loopholes Act of 2010:  health care provisions including physician payment (SGR), FMAP and Cobra.     H.R. 5440, Genomics and Personalized Medicine Act of 2010:  FDA oversight of laboratory developed tests (LDTs).", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2010-07-13T16:56:41.587000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["951924"], "units": {}, "query_ms": 0.3550139954313636, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}